Coming Soon

  • A Phase IIb Randomized, Double-blind, Parallel Placebo- and Active-controlled Study to Assess the Efficacy and Safety of Vamorolone in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD)

    Brief Description: The study is a Phase IIb randomized, double-blind, parallel group, placebo and active-controlled study to evaluate the efficacy, safety, and pharmacodynamics of vamorolone in boys with DMD. To learn more about the study eligibility and participating sites, please contact us at
    Sponsor: ReveraGen